title: Dornase alfa for cystic fibrosis.
authors: British Columbia Children's Hospital, Department of Pediatrics, Division of Respiratory Medicine, Vancouver, BC, Canada. Electronic address: connie.yang@cw.bc.ca.
authors: C L
authors: CL
authors: Yang
authors: British Columbia Children's Hospital, Department of Pediatrics, Division of Respiratory Medicine, Vancouver, BC, Canada.
authors: M
authors: M
authors: Chilvers
authors: Alberta Children's Hospital, Pediatrics and Child Health, Calgary, AB, Canada.
authors: M
authors: M
authors: Montgomery
authors: The University of Liverpool, Department of Biostatistics, Liverpool, UK.
authors: S J
authors: SJ
authors: Nolan
mesh_terms: D003550:Cystic Fibrosis / Q000188:drug therapy* / Q000401:mortality / Q000503:physiopathology; D003850:Deoxyribonuclease I / Q000627:therapeutic use*; D018450:Disease Progression; D005541:Forced Expiratory Volume; D006801:Humans; D011994:Recombinant Proteins / Q000627:therapeutic use
chemical_list: D011994:Recombinant Proteins; D003850:Deoxyribonuclease I; C568813:dornase alfa